Skip to search formSkip to main contentSkip to account menu

PD 115934

Known as: PD-115934 
National Institutes of Health

Related topics

Related topics

1 relation
NSC 366140

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Antitumor Efficacy of PD 115934 ( NSC 366140 ) against Solid Tumors of Mice 1
PD115934 (NSC 366140) is a soluble pyrazoloacridine derivative presently undergoing preclinical toxicology evaluation with the… 
2005
2005
Phase I Clinical Trial of Pyrazoloacridine N 5 C 366140 ( PD 115934 ) ’
The pyrazoloacridine (PZA) analogue NSC366140 (PD115934) entered clinical trial based on unique preclinical characteristics… 
2002
2002
PD 115934: limited activity in recurrent endometrial cancer
  • 2002
  • Corpus ID: 195141876
1995
1995
Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1.
Pharmacokinetic studies that consisted of measuring the plasma drug profile, tissue drug distribution, and elimination in urine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)